Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups

B. Durupınar; A. Saniç; M. Günaydın; M. Piirinçciler

doi:10.5835/jecm.v9i3-4.434

EN

Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups

Abstract

The hepatitis C Virus (HCV) is now known to be the chief cause of transfusion-associated non-A non-B hepatitis (NANBH). The prevalence of HCV infection was as-sessed by means of Abbott enzyme-linked immunosorbent assay for serum anti-HCV antibodies. 2222 serum samples were selected from different patient groups, accor¬ding to their risk of blood-borne viral infections. Anti-HCV antibodies were detected in 25 of 83 (30.12%) risk group (Haemodialysis patients and polytransfused patients with haemophilia, thalassemia, patients of cardiac surgery). Among healtyh subjects, wit¬hout risk factors for hepatitis, the overall prevalance of Anti-HCV was (0.14%). Hepatit C virusu (HCV), transfüzyon ile ilişkili non-A, non-B hepatiti (NANBH)'nin başlıca nedenidir. HCV infeksiyon prevalansı Abbott'un anti-HCV antikorları için enzy-me-linked immunosorbent assay (ELISA) test kiti kullanılarak saptanmıştır. 2222 serum örneği, kan yoluyla viral infeksiyon bulaşma riski olan değişik hasta gruplarından toplanmıştır. Anti-HCV antikorları 83 risk grubunun (hemodiyaliz hastası, he¬mofili, thalassemi gibi politransfüze hastalar ve kalp cerrahisi hastaları) 25 (%30.12)'inde saptanmıştır. Hepatit risk faktörü bulunmayan sağlıklı bireylerde anti-HCV prevalansı ise %0.14 olarak saptanmıştır.

Keywords

-

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

B. Durupınar This is me

A. Saniç This is me

M. Günaydın This is me

M. Piirinçciler This is me

Publication Date

December 22, 2009

Submission Date

November 24, 2009

Acceptance Date

-

Published in Issue

Year 1992 Volume: 9 Number: 3-4

DOI

https://doi.org/10.5835/jecm.v9i3-4.434

IZ

https://izlik.org/JA27ML28HW

Cite

RIS / Bibtex

APA

Durupınar, B., Saniç, A., Günaydın, M., & Piirinçciler, M. (2009). Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups. Deneysel Ve Klinik Tıp Dergisi, 9(3-4). https://doi.org/10.5835/jecm.v9i3-4.434

AMA

1.Durupınar B, Saniç A, Günaydın M, Piirinçciler M. Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups. J. Exp. Clin. Med. 2009;9(3-4). doi:10.5835/jecm.v9i3-4.434

Chicago

Durupınar, B., A. Saniç, M. Günaydın, and M. Piirinçciler. 2009. “Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups”. Deneysel Ve Klinik Tıp Dergisi 9 (3-4). https://doi.org/10.5835/jecm.v9i3-4.434.

EndNote

Durupınar B, Saniç A, Günaydın M, Piirinçciler M (December 1, 2009) Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups. Deneysel ve Klinik Tıp Dergisi 9 3-4

IEEE

[1]B. Durupınar, A. Saniç, M. Günaydın, and M. Piirinçciler, “Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups”, J. Exp. Clin. Med., vol. 9, no. 3-4, Dec. 2009, doi: 10.5835/jecm.v9i3-4.434.

ISNAD

Durupınar, B. - Saniç, A. - Günaydın, M. - Piirinçciler, M. “Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups”. Deneysel ve Klinik Tıp Dergisi 9/3-4 (December 1, 2009). https://doi.org/10.5835/jecm.v9i3-4.434.

JAMA

1.Durupınar B, Saniç A, Günaydın M, Piirinçciler M. Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups. J. Exp. Clin. Med. 2009;9. doi:10.5835/jecm.v9i3-4.434.

MLA

Durupınar, B., et al. “Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups”. Deneysel Ve Klinik Tıp Dergisi, vol. 9, no. 3-4, Dec. 2009, doi:10.5835/jecm.v9i3-4.434.

Vancouver

1.B. Durupınar, A. Saniç, M. Günaydın, M. Piirinçciler. Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups. J. Exp. Clin. Med. 2009 Dec. 1;9(3-4). doi:10.5835/jecm.v9i3-4.434